Cargando…
Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion
Most humans harbor both CD177(neg) and CD177(pos) neutrophils but 1–10% of people are CD177(null), placing them at risk for formation of anti-neutrophil antibodies that can cause transfusion-related acute lung injury and neonatal alloimmune neutropenia. By deep sequencing the CD177 locus, we catalog...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882059/ https://www.ncbi.nlm.nih.gov/pubmed/27227454 http://dx.doi.org/10.1371/journal.pgen.1006067 |
Sumario: | Most humans harbor both CD177(neg) and CD177(pos) neutrophils but 1–10% of people are CD177(null), placing them at risk for formation of anti-neutrophil antibodies that can cause transfusion-related acute lung injury and neonatal alloimmune neutropenia. By deep sequencing the CD177 locus, we catalogued CD177 single nucleotide variants and identified a novel stop codon in CD177(null) individuals arising from a single base substitution in exon 7. This is not a mutation in CD177 itself, rather the CD177(null) phenotype arises when exon 7 of CD177 is supplied entirely by the CD177 pseudogene (CD177P1), which appears to have resulted from allelic gene conversion. In CD177 expressing individuals the CD177 locus contains both CD177P1 and CD177 sequences. The proportion of CD177(hi) neutrophils in the blood is a heritable trait. Abundance of CD177(hi) neutrophils correlates with homozygosity for CD177 reference allele, while heterozygosity for ectopic CD177P1 gene conversion correlates with increased CD177(neg) neutrophils, in which both CD177P1 partially incorporated allele and paired intact CD177 allele are transcribed. Human neutrophil heterogeneity for CD177 expression arises by ectopic allelic conversion. Resolution of the genetic basis of CD177(null) phenotype identifies a method for screening for individuals at risk of CD177 isoimmunisation. |
---|